USTEKINUMAB DRUG EXPOSURE IS NOT LINKED TO CHANGES IN BOWEL WALL THICKNESS, BUT DOES ASSOCIATE WITH TRANSMURAL REMISSION IN CROHN’S DISEASE

Bram Verstockt  1     Christian Maaser  2     Rune Wilkens  3     Giovanni Maconi  4     Maria Antonietta D’Agostino  5     Maciej Nazar  6     Marjolein Lahaye  7     Omoniyi J. Adedokun  8     Manuela Le Bars  9     Ivana Bravatà  10     Lioudmila Ni  11     Mariangela Allocca  12     Floris A. E. de Voogd  13     Carolina Palmela  14     Rose Vaughan  15     Torsten Kucharzik  15    
1 Department of Gastroenterology and Hepatology, Leuven, Belgium
2 Klinik für Allgemeine Innere Medizin und Gastroenterologie, Lüneburg, Germany
3 Gastro Unit, Copenhagen, Denmark
4 Gastroenterology Unit, Milan, Italy
5 Rheumatology Unit, Rome, Italy
6 Janssen-Cilag Polska Sp. z .o.o, Warsaw, Poland
7 Janssen-Cilag B.V., Breda, Netherlands
8 Janssen Research & Development, Pennsylvania
9 Janssen-Cilag, Issy-les-Moulineaux, France
10 Janssen-Cilag S.p.A., Milan, Italy
11 Janssen-Cilag Russia, Moscow, Russian Federation
12 Department of Gastroenterology, Milan, Italy
13 Department of Gastroenterology and Hepatology, Amsterdam, Netherlands
14 Division of Gastroenterology, Loures, Portugal
15 Gastroenterology Department, Melbourne, Australia

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing